Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McGill University

$105,000.00

A study on allosteric modulators and conformational determinants that dictate beta2-adrenergic receptor structure and function.

FY 2017-18

Summary
G protein-coupled receptors (GPCRs) act at the cell surface, relaying chemically-encoded messages delivered by hormones or drugs to a network of intracellular proteins resulting in physiological effects. For instance, adrenaline binds to adrenergic receptors causing an increase in heart rate and opening of the airways. These receptors are thus important targets in drug discovery and development as we modulate their function by administering drugs. Drug-induced receptor activation leads to a reorganization of receptor "shape", thought to be a key determinant in dictating downstream physiological effects. Certain drugs can stabilize specific conformations leading to desired biological outcomes while others also generate unwanted side effects. It may be possible to regulate a drug's effect to tailor drug responses for a specific need. The main focus of my research centers around the beta2-adrenergic receptor (beta2AR), an important target for the treatment of pulmonary and cardiovascular diseases, conditions that many Canadians suffer from. My goal is to understand the link between receptor "shape" and function and to uncover ways that receptor shape or conformation can change in response to environmental factors. For this purpose, we engineered conformation-sensitive biosensors as part of a pharmacological toolkit to report on changes in beta2AR conformation adopted upon drug binding. These biosensors provide us with tools to study the conformational landscape of the beta2AR as well as a method to identify which drugs or associated signaling partners influence its conformation. Altogether, these biosensors will allow us to gain a more complete understanding of the underlying molecular mechanisms that govern receptor conformation and function. Our approach will allow 'fine-tuning' of drug responses as we will gain information on how to better target the beta2AR in a therapeutic context.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
383289
Name
Bourque Kyla
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
A study on allosteric modulators and conformational determinants that dictate beta2-adrenergic receptor structure and function.
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Allostery; Beta2-Adrenergic Receptor; Cellular Signaling; Dna Aptamers; Drug Discovery; Flash-Bret; Gpcrs; Ipscs; Nanobodies; Resonance Energy Transfer
Abstract
G protein-coupled receptors (GPCRs) act at the cell surface, relaying chemically-encoded messages delivered by hormones or drugs to a network of intracellular proteins resulting in physiological effects. For instance, adrenaline binds to adrenergic receptors causing an increase in heart rate and opening of the airways. These receptors are thus important targets in drug discovery and development as we modulate their function by administering drugs. Drug-induced receptor activation leads to a reorganization of receptor "shape", thought to be a key determinant in dictating downstream physiological effects. Certain drugs can stabilize specific conformations leading to desired biological outcomes while others also generate unwanted side effects. It may be possible to regulate a drug's effect to tailor drug responses for a specific need. The main focus of my research centers around the beta2-adrenergic receptor (beta2AR), an important target for the treatment of pulmonary and cardiovascular diseases, conditions that many Canadians suffer from. My goal is to understand the link between receptor "shape" and function and to uncover ways that receptor shape or conformation can change in response to environmental factors. For this purpose, we engineered conformation-sensitive biosensors as part of a pharmacological toolkit to report on changes in beta2AR conformation adopted upon drug binding. These biosensors provide us with tools to study the conformational landscape of the beta2AR as well as a method to identify which drugs or associated signaling partners influence its conformation. Altogether, these biosensors will allow us to gain a more complete understanding of the underlying molecular mechanisms that govern receptor conformation and function. Our approach will allow 'fine-tuning' of drug responses as we will gain information on how to better target the beta2AR in a therapeutic context.
Competitiondate
201710
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bourque, Kyla
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
McGill University - $105,000 Grant (2017-18) | Canada Spends